Europe - Frankfurt Stock Exchange - FRA:PSG - DE000A2P4LJ5 - Common Stock
The current stock price of PSG.DE is 29 EUR. In the past month the price increased by 0.69%. In the past year, price increased by 39.42%.
ChartMill assigns a technical rating of 10 / 10 to PSG.DE. When comparing the yearly performance of all stocks, PSG.DE is one of the better performing stocks in the market, outperforming 86.34% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to PSG.DE. PSG.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months PSG.DE reported a non-GAAP Earnings per Share(EPS) of 1.37. The EPS increased by 37.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.22% | ||
| ROA | 13.88% | ||
| ROE | 44.72% | ||
| Debt/Equity | 1.58 |
6 analysts have analysed PSG.DE and the average price target is 38.76 EUR. This implies a price increase of 33.66% is expected in the next year compared to the current price of 29.
For the next year, analysts expect an EPS growth of 28.05% and a revenue growth 15.62% for PSG.DE
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 10.85 | 200.25B | ||
| SNW.DE | SANOFI | 10.76 | 198.69B | ||
| SAN.PA | SANOFI | 10.63 | 196.21B | ||
| MRK.DE | MERCK KGAA | 15.24 | 56.52B | ||
| UNC.DE | UCB SA | 40.61 | 50.71B | ||
| UCB.BR | UCB SA | 41.37 | 51.66B | ||
| 1BAYN.MI | BAYER AG-REG | 7.9 | 41.45B | ||
| BAYN.DE | BAYER AG-REG | 7.77 | 40.79B | ||
| IPN.PA | IPSEN | 13.1 | 11.27B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 113.22 | 10.48B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.36 | 10.03B | ||
| VIRP.PA | VIRBAC SA | 20.5 | 2.98B |
PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.
PHARMASGP HOLDING SE
Lochhamer Schlag 21
Graefelfing BAYERN DE
Employees: 89
Phone: 49898589639150
PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.
The current stock price of PSG.DE is 29 EUR.
PHARMASGP HOLDING SE (PSG.DE) has a dividend yield of 1.76%. The yearly dividend amount is currently 0.49.
PSG.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
6 analysts have analysed PSG.DE and the average price target is 38.76 EUR. This implies a price increase of 33.66% is expected in the next year compared to the current price of 29.
PHARMASGP HOLDING SE (PSG.DE) will report earnings on 2025-09-11.
You can find the ownership structure of PHARMASGP HOLDING SE (PSG.DE) on the Ownership tab.